Recurring Revenue Accelerates, But Margin Pressure Clouds FY27 Outlook

What happened

Broadridge reported first-quarter fiscal 2027 results with recurring revenue growing 11% on a reported and constant currency basis to $1,083 million, but adjusted EPS rose only 3% to $1.56, well below the full-year guidance of 8-12% growth. Total revenue increased 5% to $1,669 million, driven by the recurring business, while operating income declined 8% to $174 million and operating margin contracted 150 basis points to 10.4%. Adjusted operating margin fell 200 basis points to 13.8%, reflecting higher costs likely tied to acquisitions and modernization investments. Management reaffirmed its full-year guidance, citing closed sales growth of 10% to $36 million and continued traction in digital engagement and tokenization. However, the stark divergence between strong top-line growth and weak bottom-line growth raises questions about the base of profitability and the achievability of FY27 EPS targets without meaningful margin repair.

Implication

The Q1 print shows recurring revenue momentum above guidance, but profitability is lagging, which could signal that acquisition integration and modernization costs are heavier than expected. Management's reaffirmation of full-year guidance implies a significant acceleration in adjusted EPS growth over the remaining three quarters, a feat that requires either sharper cost controls or a favorable mix shift. Closed sales of $36 million in Q1 annualize to only about $144 million, well below the $290-330 million guidance, though Q1 is seasonally the weakest quarter and the company expects a back-half weighted sales pipeline. The margin contraction, if persistent, would undermine the investment thesis that Broadridge can deliver operating leverage as it scales digital and AI-driven solutions. Until there is evidence of margin stabilization and EPS growth catching up to revenue growth, investors should treat the stock's re-rating potential with caution and use any strength as an opportunity to reassess position size.

Thesis delta

The investment thesis is mildly weakened by the Q1 results, as the strong recurring revenue growth is offset by a 200 basis point decline in adjusted operating margin and only 3% adjusted EPS growth. The master report had projected 6-8% recurring growth and 8-12% adjusted EPS growth for FY27, but Q1 delivered 11% recurring growth and 3% adjusted EPS growth, suggesting that margin compression is real and not just a timing issue. While management reaffirmed guidance, the credibility of the full-year EPS target now depends on a sharp acceleration in profitability, which lowers our conviction from 'potential buy' to 'hold and monitor' until margin trends improve.